Federated Hermes Inc. Sells 1,835 Shares of Maximus, Inc. (NYSE:MMS)

Federated Hermes Inc. lessened its stake in shares of Maximus, Inc. (NYSE:MMSFree Report) by 0.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 541,853 shares of the health services provider’s stock after selling 1,835 shares during the period. Federated Hermes Inc.’s holdings in Maximus were worth $45,440,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. VisionPoint Advisory Group LLC increased its position in shares of Maximus by 61.4% in the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock worth $28,000 after purchasing an additional 145 shares during the period. Metropolitan Life Insurance Co NY increased its holdings in Maximus by 4.4% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 3,813 shares of the health services provider’s stock valued at $280,000 after buying an additional 162 shares during the period. Captrust Financial Advisors raised its position in shares of Maximus by 14.9% in the 2nd quarter. Captrust Financial Advisors now owns 1,303 shares of the health services provider’s stock valued at $81,000 after buying an additional 169 shares in the last quarter. Cetera Investment Advisers lifted its holdings in shares of Maximus by 4.5% during the 1st quarter. Cetera Investment Advisers now owns 4,253 shares of the health services provider’s stock worth $319,000 after acquiring an additional 184 shares during the period. Finally, Belpointe Asset Management LLC increased its stake in Maximus by 7.8% in the first quarter. Belpointe Asset Management LLC now owns 3,089 shares of the health services provider’s stock valued at $243,000 after acquiring an additional 224 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on MMS shares. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 3rd. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th.

View Our Latest Stock Analysis on Maximus

Insider Transactions at Maximus

In related news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 1.40% of the company’s stock.

Maximus Stock Up 1.7 %

NYSE:MMS opened at $81.44 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. Maximus, Inc. has a one year low of $72.39 and a one year high of $89.69. The firm’s 50 day simple moving average is $82.69 and its 200 day simple moving average is $81.10. The company has a market cap of $4.97 billion, a PE ratio of 26.97 and a beta of 0.72.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.06. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. Maximus’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.94 earnings per share. On average, research analysts anticipate that Maximus, Inc. will post 5.41 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date is Tuesday, May 14th. Maximus’s dividend payout ratio is presently 39.74%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.